Martek Announces Settlement of Patent Dispute with Capsugel France

Additionally, Martek and Capsugel will develop a product containing Martek's algal DHA in Capsugel's proprietary Licaps liquid-filled hard capsules.

11 Sep 2009 --- DHA omega-3 innovator and maker of the life'sDHA brand, Martek Biosciences Corporation, announced it has resolved a patent dispute with Capsugel France. The resolution follows Martek's November 2008 action for infringement filed in the High Court of Strasbourg, France.

As a result of this settlement agreement between Martek and Capsugel France, Capsugel and all of its affiliates have agreed to purchase all of their algal DHA exclusively from Martek for the life of the patent in question. Additionally, Martek and Capsugel will develop a product containing Martek's algal DHA in Capsugel's proprietary Licaps liquid-filled hard capsules.

This settlement agreement between Martek and Capsugel does not include Martek's action against Lonza Ltd AG, which continues.